DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mozobil (Plerixafor Subcutaneous) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (151)
Death (48)
Life Threatening Events (19)
Disability (4)

Reports by Reaction Type

Febrile Neutropenia (30)Nausea (21)Respiratory Failure (15)Pleural Effusion (14)Sepsis (12)Death (11)Hypotension (11)Interstitial Lung Disease (10)Pneumonia (10)Therapeutic Response Decreased (10)Diarrhoea (10)Insomnia (10)

Below are a few examples of reports where side effects / adverse reactions may be related to Mozobil (Plerixafor Subcutaneous). For a complete list or a specific selection of reports, please use the links above.

Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-22

Patient: female

Reactions: Pulmonary Embolism, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Mozobil
    Indication: Lymphoma Transformation

Mozobil
    Dosage: 15.36 mg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2011-04-27
    End date: 2011-04-29

Other drugs received by patient: Neupogen; Terbinafine HCL; Centyl MED Kaliumklorid; Acyclovir



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: female, weighing 69.1 kg (152.0 pounds)

Reactions: Abdominal Pain, Vomiting, Pneumonia, Nausea, Pain, Orthostatic Hypotension, Headache, Hypoaesthesia, Constipation, Rash Pruritic, Paraesthesia, Fatigue, Insomnia, Dizziness, Decreased Appetite

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Zyrtec; Senna; Etoposide; Cytarabine; Fiberall; Demerol; Vitamin B Complex CAP; Compazine; Fiber Pills; Magnesium; Mitoxantrone; Sodium Chloride; Dexamethasone; Levothyroxine Sodium; Flonase; Benadryl; Ativan; Celexa; Estrogen NOS; Oxycodone HCL; Demerol; Multi-Vitamin; Colace; Neupogen; Allopurinol; Albuterol; Chlordiazepoxide W; Imipramine HCL; Vitamin E; Vitamin D; Zofran



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 108.0 kg (237.6 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 25.0 kg (55.0 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: 70 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: 254 mg, qd
    Start date: 2012-06-16
    End date: 2012-06-19

Thymoglobulin
    Dosage: 229.9 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: female, weighing 91.1 kg (200.4 pounds)

Reactions: Cellulitis, Nausea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Voriconazole; Etoposide; Piperacillin W; Ondansetron; Hydrocortisone; Neupogen; Dilaudid; Tylenol-500; Linezolid; Cytarabine; Mitoxantrone; Benadryl



Possible Mozobil side effects in 59 year old female

Reported by a physician from United States on 2012-08-20

Patient: 59 year old female, weighing 58.9 kg (129.6 pounds)

Reactions: White Blood Cell Count Decreased, Blood Bilirubin Increased, Jaundice, Hepatic Function Abnormal, Haematuria, Alanine Aminotransferase Increased, Cystitis, Fatigue, Diarrhoea, Aspartate Aminotransferase Increased, Platelet Count Decreased, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluconazole
    Dosage: unk
    Indication: Antifungal Treatment
    End date: 2012-07-24

Mozobil
    Dosage: unk, 2 cycles
    Indication: Acute Myeloid Leukaemia

Neupogen
    Dosage: unk, 2 cycles
    Indication: Acute Myeloid Leukaemia

Sorafenib
    Dosage: unk, 2 cycles
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Antibacterial NOS; Antivirals NOS



Possible Mozobil side effects in male

Reported by a physician from Denmark on 2012-08-20

Patient: male, weighing 119.0 kg (261.8 pounds)

Reactions: C-Reactive Protein Increased, Tremor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Levothyroxine Sodium; Aspirin; Neupogen Novum; Pantoprazole; Simvastatin; Metoprolol Succinate



Possible Mozobil side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-17

Patient: male, weighing 72.6 kg (159.7 pounds)

Reactions: Acute Myeloid Leukaemia, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Clofarabine
    Dosage: 37 mg, qd
    Start date: 2012-02-02
    End date: 2012-02-05

Clofarabine
    Dosage: 37 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-30
    End date: 2012-01-30

Mozobil
    Dosage: 17.4 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-30
    End date: 2012-01-30

Mozobil
    Dosage: 17.4 mg, qd
    Start date: 2012-02-01
    End date: 2012-02-04

Vancomycin
    Dosage: 1 g, bid
    Indication: Sepsis
    Start date: 2012-02-05
    End date: 2012-02-07

Other drugs received by patient: Daunorubicin HCL; Potassium Chloride; Nicotine; Fluticasone Propionate / Salmeterol; Acetaminophen and Codeine Phosphate; Ondansetron; Potassium Chloride; Allopurinol; Daunorubicin HCL; Cyclizine; Furosemide; Ipratropium Bromide; Chlordiazepoxide; Itraconazole; Acyclovir; Meropenem; Meropenem; Acetaminophen and Codeine Phosphate; Calcium Carbonate; Daunorubicin HCL



Possible Mozobil side effects in male

Reported by a physician from France on 2012-08-17

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 2050 mg, qd, days 8-10
    Start date: 2012-04-26
    End date: 2012-04-28

Cytarabine
    Dosage: 1050 mg, qd, days 1-3
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-19
    End date: 2012-04-21

Daunorubicin HCL
    Dosage: 125 mg, qd, days 1-3
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-19
    End date: 2012-04-21

Granocyte
    Dosage: 410 mcg, qd, days 1-10
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-19
    End date: 2012-04-28

Mozobil
    Dosage: 240 mcg/kg, qd, days 1-3
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-19
    End date: 2012-04-21

Mozobil
    Dosage: 240 mcg/kg, qd, days 8-10
    Start date: 2012-04-26
    End date: 2012-04-28

Mozobil



Possible Mozobil side effects in male

Reported by a physician from France on 2012-08-17

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Bone Pain

Drug(s) suspected as cause:
Granocyte
    Dosage: 430 mcg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-22
    End date: 2012-02-22

Mozobil
    Dosage: 15840 mcg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-22
    End date: 2012-02-22

Other drugs received by patient: Morphine; Oxycodone Hydrochloride; Nefopam; Cytarabine; Daunorubicin HCL



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-08-13

Patient: female, weighing 25.2 kg (55.4 pounds)

Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension

Adverse event resulted in: death, life threatening event, disablity

Drug(s) suspected as cause:
Clolar
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-10
    End date: 2012-01-11

Fludara
    Dosage: 140 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-15

Mozobil
    Dosage: 6 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-06-16
    End date: 2012-06-18

Thymoglobulin
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-15
    End date: 2012-01-18

Thymoglobulin
    Dosage: unk
    Start date: 2012-06-16
    End date: 2012-06-19

Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09

Patient: female, weighing 44.0 kg (96.8 pounds)

Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Meropenem; Etoposide; Cytarabine; Acetaminophen; Morphine Sulfate; Ondansetron; Vancomycin; Solutions FOR Parenteral Nutrition



Possible Mozobil side effects in male

Reported by a physician from United States on 2012-08-07

Patient: male

Reactions: Cerebral Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Mozobil
    Dosage: unk
    Indication: Haematopoietic Stem Cell Mobilisation
    End date: 2012-07-25

Mozobil
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: female

Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Cytarabine; Morphine Sulfate; Ondansetron; Etoposide; Solutions FOR Parenteral Nutrition; Vancomycin; Acetaminophen; Meropenem



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: female, weighing 85.9 kg (189.0 pounds)

Reactions: White Blood Cell Count Decreased, Acute Myeloid Leukaemia, Pulmonary Alveolar Haemorrhage, Febrile Neutropenia, Lung Infection Pseudomonal, Pseudomonal Bacteraemia, Multi-Organ Failure, Respiratory Failure, Platelet Count Decreased, Cardiac Arrest, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Neupogen; Carvedilol; Cefpodoxime Proxetil; Polyethylene Glycol; Valacyclovir Hydrochloride; Furosemide; Fluconazole; Temazepam; Fluticasone W; Tramadol HCL; Lansoprazole; Nifedipine; Nifedipine; Docusate Sodium W; Ondansetron Hydrochloride; Potassium Chloride; Levothyroxine Sodium; Sorafenib; Heparin; Lisinopril



Possible Mozobil side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Sepsis, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Lorazepam; Mitoxantrone; Morphine Sulfate; Neupogen; Etoposide; Cytarabine; Hydrocodone Bitartrate



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-07-20

Patient: female, weighing 69.1 kg (152.0 pounds)

Reactions: Abdominal Pain, Pneumonia, Vomiting, Nausea, Pain, Orthostatic Hypotension, Hypoaesthesia, Headache, Constipation, Paraesthesia, Rash Pruritic, Fatigue, Insomnia, Dizziness, Decreased Appetite

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Mitoxantrone; Celexa; Fiberall; Vitamin B Complex CAP; Multi-Vitamin; Colace; Benadryl; Allopurinol; Albuterol; Imipramine HCL; Zyrtec; Demerol; Vitamin D; Neupogen; Dexamethasone; Oxycodone HCL; Magnesium Sulfate; Etoposide; Sodium Chloride; Ativan; Flonase; Cytarabine; Chlordiazepoxide W; Estrogen NOS; Senna-Mint WAF; Zofran; Fiber Pills; Vitamin E; Levothyroxine Sodium; Demerol; Compazine



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19

Patient: female

Reactions: White Blood Cell Count Decreased, Atelectasis, Pneumonia, Platelet Count Decreased, Febrile Neutropenia, Pulmonary Fibrosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Neupogen; Sorafenib



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female

Reactions: Therapeutic Response Decreased, Pleural Effusion, Lobar Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Cytarabine; Meropenem; Ondansetron; Vancomycin; Etoposide; Acetaminophen; Morphine Sulfate; Solutions FOR Parenteral Nutrition



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 91.1 kg (200.4 pounds)

Reactions: Cellulitis, Nausea, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Etoposide; Linezolid; Ondansetron; Voriconazole; Hydrocortisone; Mitoxantrone; Neupogen; Dilaudid; Cytarabine; Piperacillin W; Acetaminophen; Benadryl



Possible Mozobil side effects in female

Reported by a physician from United States on 2012-07-16

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin



Possible Mozobil side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: female, weighing 92.1 kg (202.6 pounds)

Reactions: Myalgia, Vomiting, Nausea, Diarrhoea, Hypotension, Oedema, Headache

Drug(s) suspected as cause:
Mozobil
    Dosage: 52000 mcg, unk
    Start date: 2011-11-10
    End date: 2011-11-10

Mozobil
    Dosage: 52000 mcg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-11-09
    End date: 2011-11-09

Mozobil
    Dosage: 52000 mcg, unk
    Start date: 2011-11-11
    End date: 2011-11-14

Other drugs received by patient: Neupogen; Mitoxantrone; Cytarabine; Hydrochlorothiazide; Etoposide; Citalopram Hydrobromide; Lisinopril; Multi-Vitamin; Klor-CON



Possible Mozobil side effects in 74 year old female

Reported by a physician from United States on 2012-07-11

Patient: 74 year old female, weighing 67.6 kg (148.7 pounds)

Reactions: Atelectasis, Hyperglycaemia, Hypotension, General Physical Health Deterioration, Hypercalcaemia, Ascites, Diarrhoea, Decubitus Ulcer, Urinary Tract Infection Bacterial, Dehydration, Hypomagnesaemia, Pleural Effusion, Splenic Haemorrhage, Diffuse Large B-Cell Lymphoma, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Filgrastim
    Dosage: 570 mcg, qd
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2012-01-25
    End date: 2012-02-01

Mozobil
    Dosage: 22840 mcg, qd
    Start date: 2012-01-31
    End date: 2012-02-01

Mozobil
    Dosage: 22840 mcg, qd
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-01-30
    End date: 2012-01-30

Mozobil
    Dosage: 13704 mcg, once
    Indication: Haematopoietic Stem Cell Mobilisation
    Start date: 2012-01-25
    End date: 2012-01-25

Other drugs received by patient: Vitamin D; Heparin Lock-Flush; Magic Mouthwash; HP Supplement; Miralax; Steroid Therapy; Fluorodeoxyglucose F 18; Oxycodone HCL; Oxycodone HCL; Acetaminophen; Furosemide; Calcium Citrate; Potassium Chloride; Colace



Possible Mozobil side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-09

Patient: male

Reactions: White Blood Cell Count Decreased, Fatigue, Anaemia, Chest Pain, Peritonsillar Abscess, Pyrexia, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: unk
    Indication: Acute Leukaemia
    Start date: 2012-04-20

Daunorubicin HCL
    Dosage: unk
    Indication: Acute Leukaemia
    Start date: 2012-04-20

Mozobil
    Dosage: unk
    Indication: Acute Leukaemia
    Start date: 2012-04-20



Possible Mozobil side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Sepsis, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Etoposide; Cytarabine; Mitoxantrone; Hydrocodone; Neupogen; Morphine; Lorazepam



Possible Mozobil side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 56 year old male

Reactions: Sepsis, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Mitoxantrone; Cytarabine; Granulocyte Colony Stimulating Factor; Etoposide



Possible Mozobil side effects in male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-29

Patient: male, weighing 72.6 kg (159.7 pounds)

Reactions: Acute Myeloid Leukaemia, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Clofarabine
    Dosage: 37 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-30
    End date: 2012-01-30

Clofarabine
    Dosage: 37 mg, qd
    Start date: 2012-02-02
    End date: 2012-02-05

Mozobil
    Dosage: 17.4 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-30
    End date: 2012-01-30

Mozobil
    Dosage: 17.4 mg, qd
    Start date: 2012-02-01
    End date: 2012-02-04

Vancomycin
    Dosage: 1 g, bid
    Indication: Sepsis
    Start date: 2012-02-05
    End date: 2012-02-07

Other drugs received by patient: Itraconazole; Meropenem; Meropenem; Ondansetron; Cyclizine; Daunorubicin HCL; Fluticasone Propionate / Salmeterol; Daunorubicin HCL; Acyclovir; Potassium Chloride; Allopurinol; Calcium Carbonate; Furosemide; Ipratropium Bromide; Nicotine; Acetaminophen and Codeine Phosphate; Potassium Chloride; Daunorubicin HCL; Acetaminophen and Codeine Phosphate; Chlordiazepoxide



Possible Mozobil side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 65 year old male

Reactions: Arrhythmia Supraventricular, Blood Pressure Systolic Decreased, Dyspnoea, Hypothermia, Hyperkalaemia, Anaemia, Ascites, Chronic Lymphocytic Leukaemia, Pleural Effusion, Thrombocytopenia, Asthenia, White Blood Cell Count Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Mozobil

Other drugs received by patient: Acyclovir; Pantoprazole; Simvastatin; Prochlorperazine; Tamsulosin HCL; Lenalidomide; Hydrocodone W; Temazepam; Trimethoprim + Sulfamethoxazole

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014